ABSTRACT -Monkey cerebral artery strips partially contracted with prostaglandin F2a responded to histamine with biphasic patterns of relaxation. The delayed and sustained relaxation was suppressed by cimetidine, whereas the phasic response was abolished by treatment with chlorpheniramine and NG nitro-L-arginine (L-NA), a nitric oxide (NO) synthase inhibitor. The inhibition by L-NA was reversed by L-arginine. D-NA was without effect. Endothelium denudation abolished the phasic relaxation. We hypothesized that endothelium-dependent, phasic relaxations caused by histamine are mediated by NO that is released by Hi-receptor stimulation, whereas the sustained relaxation is associated with the activation of H2-receptors in the smooth muscle of monkey cerebral arteries.
The complexity of vascular responses to histamine is based on its actions on histaminergic receptor subtypes, H1 and H2, in the endothelium and smooth muscle and on the release of chemical mediators, such as endothelium-derived relaxing factor (EDRF) and pros taglandins (PGs), from endothelial and subendothelial tissues (1 6) . Histamine-induced relaxations mediated by EDRF have been reported in human, monkey and rabbit cerebral arteries (7, 8) ; human and monkey coronary arteries (9, 10) ; guinea pig pulmonary arteries (11) ; human umbilical vessels (12) ; monkey pulmonary veins (13) ; and rat aortas (14) . The participation of EDRF is postulated from evidence that the relaxation is dependent on the endothelium and is suppressed by treatment with oxyhemoglobin, methylene blue or anti oxidants. EDRF has been proposed to be nitric oxide (NO) or an unstable S-nitroso compound that releases the NO radical (15, 16) . However, endothelium-depend ent relaxations are not always associated with NO or its analog (17, 18) .
We have reported that endothelium-dependent re laxations caused by histamine in monkey cerebral arter ies are significantly inhibited by methylene blue and chlorpheniramine, suggesting the involvement of the endothelial H1-receptor subtype in the release of EDRF (7) . Despite this conclusion, whether NO was actually involved in the response could not be determined. Methylene blue has many actions other than the inhibi tion of soluble guanylate cyclase (19, 20) , whereas NO synthase inhibitors, including NG-monomethyl-L-argi nine, NG-nitro-L-arginine (L-NA), L-NA methylester, etc. (21) , are selective in depressing the synthesis of NO. Thus, the role of NO can be evaluated more speci fically by the use of these inhibitors. In addition, the effectiveness of NO synthase inhibitors on the endo thelium-dependent relaxation has not been evaluated in cerebral arteries.
Therefore, the present study was undertaken to eluci date the involvement of endothelium-derived NO in the histamine-induced relaxation of isolated monkey cere bral arteries, with special reference to the histaminergic receptor subtypes.
MATERIALS AND METHODS

Preparation
Japanese monkeys (Macaca fuscata) of either sex, weighing 6 to 12 kg, were anesthetized with intramuscu lar injections of ketamine (40 mg/kg) and sacrificed by bleeding from the carotid arteries. The brain was rapid ly removed. Middle cerebral and basilar arteries were isolated from the brain. The arteries were helically cut into approximately 20-mm-long strips, with special care to preserve an intact endothelium. The specimen was vertically fixed between hooks in a muscle bath contain ing the modified Ringer-Locke solution, which was maintained at 37 ± 0.3°C and aerated with a mixture of 95% 02 and 5% CO2. The hook anchoring the upper end of the strip was connected to the lever of a force displacement transducer. The resting tension was ad justed to 1.0 g, which is optimal for inducing the max imal contraction. The composition of the bathing media was as follows: 120 mM NaCI, 5.4 mM KCI, 2.2 mM CaC12, L0 MM MgC12, 25.0 mM NaHCO3 and 5.6 mM dextrose. The pH of the solution was 7.37 to 7.42. All of the strips were allowed to equilibrate for 60 to 90 min in the bathing media, during which time the fluids were replaced three times every 10 to 15 min.
Recording
Isometric contractions and relaxations were recorded on an inkwriting oscillograph (Nihon Kohden Kogyo Co., Tokyo, Japan). The contractile response to 30 mM K+ was first obtained, and then the artery strips were repeatedly washed with fresh media and equilibrated. The strips were partially contracted with prostaglandin (PG) F2a (10' to 7 X 10' M), the contraction being in a range between 20 and 32% of the contraction in duced by 30 mM K+. Concentration-response curves for histamine were obtained by adding the agent direct ly to the bathing media in cumulative concentrations. At the end, papaverine (104 M) was applied to attain the maximal relaxation, which was taken as a standard for agonist-induced relaxations. Contractions induced by histamine were presented as relative values to con tractions caused by 30 mM K+. The artery strips had been treated for 20 to 30 min with blocking agents, be fore the concentration-response curve for histamine was obtained. The endothelium was removed by gently rub bing the endothelial surface with a cotton pellet. Re moval of the endothelium was determined by abolish ment or marked suppression of relaxations caused by 10-' M Ca 2+ ionophore A23187.
Statistics and drugs used
The results shown in the text and figures were ex pressed as mean values ± S.E.M. Statistical analyses were made by Student's unpaired t-test and Tukey's method after one-way analysis of variance. Drugs used were histamine hydrochloride (Kanto Chemical Co., Tokyo), NG-nitro-L-arginine (L-NA), NG-nitro-o-argi nine (D-NA; Peptide Institute, Minoh, Japan), L-argi nine (Nacalai Tesque, Kyoto, Japan), d-chlorphenir amine maleate (Schering Coop., Kenilworth, NJ), cime tidine (Fujisawa Co., Osaka, Japan), Ca 2+ ionophore A23187 (C.H. Boehringer Ingelheim, Ltd., Elmford, NY), prostaglandin (PG) F2,, (Toray Co., Tokyo) and papaverine hydrochloride (Dainippon Co., Osaka). report (7), the relaxation was constructed by phasic and sustained phases, except for the response to high con centrations which elicited a nearly maximal, sustained relaxation. Treatment with 106 M L-NA abolished the phasic relaxation and also attenuated the sustained phase, as shown in Fig. 1 . The quantitative data are summarized in the left panel of Fig. 2 . D-NA up to 105 M did not alter the response to the amine (n = 3). In the strips in which the amine-induced relaxation was suppressed by L-NA, the additon of L-arginine (3 X 104 M) restored the response (Fig. 2) . The restored relaxation was abol ished by treatment with 106 M chlorpheniramine (Fig.  2) . In the strips treated with 105 M cimetidine, chlor pheniramine almost abolished the response (Fig. 1, bot  tom tracing) .
Treatment with cimetidine (10-5 M) markedly re duced the sustained relaxation induced by histamine, making the phasic response quite evident (Fig. 3, 2nd  tracing) . A significant shift by cimetidine to the right of the concentration-response curve for histamine is illus trated in the left panel of Fig. 4 . The phasic relaxation was abolished or reversed to a contraction by treatment with 10-6 M L-NA (Figs. 3 and 4) . The addition of L arginine (3 X 10-4 M) completely reversed the inhibi tory effect of L-NA. The re-appearing phasic response was markedly attenuated by 10-6 M chlorpheniramine ( Fig. 3 and Fig. 4, right panel) . The remaining relaxa tions at 2 X 10-6 and 10-5 M in the bottom tracing of Fig. 3 were abolished by raising the concentration of cimetidine to 10-4 M.
The phasic relaxation induced by histamine was abol ished by endothelium denudation, which also signifi cantly attenuated the tonic relaxation; average relaxa tions in the endothelium-intact and -damaged strips were 33.6 ± 6.5 and 6.6 ± 2.8% (n = 5, P < 0.01), re spectively, at 5 X 10-7 M histamine, and they were 59.2 ± 7.1 and 30.0 ± 8.2% (n = 5, P < 0.01), respec tively, at 2 X 10-6 M. 
DISCUSSION
The present study revealed that histamine elicited a biphasic pattern of relaxation in the monkey cerebral artery strips. Treatment with cimetidine, a histamine H2-receptor antagonist, resulted in only the phasic pat tern (Fig. 3) , which was abolished by chlorpheniramine, an H,-antagonist. The phasic relaxation was abolished or reversed to a contraction by treatment with L-NA, an NO synthase inhibitor (22) , but not by D-NA; and the inhibitory effect was reversed by L-arginine. The phasic response was endothelium-dependent. Indometh acin does not alter the response (7). These findings are consistent with the view that the phasic relaxation is assoicated with the activation of Ht-receptors in the en dothelium, resulting in the synthesis and release of NO, whereas the delayed and sustained phase is mediated by H2-receptors in smooth muscle. Such a clear phasic pat tern of relaxation shown in this study on monkey cere bral arteries treated with cimetidine has not been re ported in other blood vessels of a variety of mammals, although similar tendencies have been observed in monkey coronary arteries and dog mesenteric arteries (2, 9) . According to the literature, Hi-receptors in hu man, cat and rabbit cerebral arteries (7, (23) (24) (25) and H3-receptors in rabbit cerebral arteries (26) are re sponsible for the histamine-induced relaxation, whereas the relaxation of rat cerebral arteries are mediated by EDRF released by the activation of H2-receptors (27) .
The results obtained in this study suggest that EDRF released by a mediation of H1-receptors is exclusively NO in monkey cerebral arteries. Chlorpheniramine and L-NA share inhibitory effects on the endothelium dependent relaxation; however, chlorpheniramine also suppresses the contraction associated with H1-receptor stimulation in smooth muscle (cf. the third and fifth tracings in Fig. 3) .
In primate blood vessels so far obtained, including cerebral and coronary arteries, pulmonary veins and umblical blood vessels, the H1-receptor subtype is re sponsible for the histamine-induced, endothelium dependent relaxation. Hi-receptor stimulation of cul tured endothelial cells of the human umbilical vein in creases intracellular Ca 2+ (28, 29) . Release of EDRF from human coronary artery (N. Toda et al., unpub lished data) and umbilical blood vessel segments (12) with the intact endothelium stimulated by histamine is detected by a bioassay system. In the present study, in volvement of endothelium-derived NO in the histamine induced relaxation in monkey cerebral arteries was dem onstrated. Cyclic GMP levels in human coronary arter ies are increased by stimulation with histamine (30) . These results strongly support the hypothesis that in primate blood vessels, stimulation of the histaminergic Hi-receptor subtype in endothelial cells increases intra cellular Ca 2+, resulting in activation of NO synthase, and the released NO stimulates the soluble guanylate cyclase in smooth muscle and increases the production of cyclic GMP that is responsible for muscle relaxation. . The arteries were contracted with PGF20. Relaxation induced by 10-4 M papaverine were taken as 100% relaxation; mean absolute values for the four curves in the left panel were 253 ± 35 mg, 253 ± 35 mg, 293 ± 14 mg and 309 ± 78 mg (n = 4), respectively, and those for the two curves in the right panel were 309 ± 78 mg and 273 ± 38 mg (n = 4), respectively. Contractions induced by 30 mM K+ were taken as 100% contraction; the mean absolute value in the strips treated with cimetidine and L-NA was 1258 ± 221 mg (n = 4). Significantly different from the control: ap < 0.01, 6P < 0.05. Significantly different from the value with cimetidine: `P < 0.01, dP < 0.05. Significantly different from the value with cimetidine plus L-NA: ep < 0.01, fP < 0.05 (Tukey's method). Significantly different from the value with L-NA Plus L-arginine: gp < 0.01, hp < 0.05 (unpaired t-test). Vertical bars rep resent the S.E.M.
